The latest financial report from Candel Therapeutics shows an operating loss of $15.752 million in the fourth quarter, significantly higher than the $13.9 million loss widely forecasted by IBES analysts.

The latest financial report from Candel Therapeutics shows an operating loss of $15.752 million in the fourth quarter, significantly higher than the $13.9 million loss widely forecasted by IBES analysts.

老虎证券2026/03/12 12:21

Show original

Bitget offers a variety of ways to buy or sell popular cryptocurrencies.Buy now!

A welcome pack worth 6200 USDT for new users!Sign up now!

Actual performance significantly deviates from market expectations, reflecting that the company's operational results for the period did not meet market consensus.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The latest financial report from Candel Therapeutics shows an operating loss of $15.752 million in the fourth quarter, significantly higher than the $13.9 million loss widely forecasted by IBES analysts.

You may also like

Trending news

Crypto prices